Table 1.
Study | Design | N | Interventions | Follow-up | Pain relief (%)* |
Endoscopy | |||||
Rosch et al 12 | Cohort | 1018 | Endoscopy (including ESWL) | 4.9 years† | 65 |
Tadenuma et al 71 | Cohort | 57 | Endoscopy (including ESWL) | 1 year | 63 |
Dumonceau et al 72 | RCT | 55 | ESWL with/without subsequent endoscopy | 2 years | 55 vs 62 (p=0.651) |
Conventional surgery | |||||
Dite et al
61
|
RCT | 72 | Endoscopy (without ESWL) versus surgery | 5 years | 61 vs 86 (p=0.002) |
Cahen et al 13 | RCT | 39 | Endoscopy (including ESWL) versus surgery | 2 years | 32 vs 75 (p=0.007) |
Cahen et al26 | Long-term results RCT | 31 | Endoscopy (including ESWL) versus surgery | >6 years | 38 vs 80 (p=0.042) |
TPIAT | |||||
Bellin et al 82 | Cohort | 215 | TPIAT | 10 years | 82 |
Neuropathic pain medication | |||||
Olesen et al67 | RCT | 64 | Pregabalin versus placebo | 3 weeks | 36 vs 24 (p=0.02) |
*Complete and partial pain relief combined.
†Mean.
CP, chronic pancreatitis; ESWL, extracorporeal shockwave lithotripsy; RCT, randomised controlled trial; TPIAT, total pancreatectomy with islet autotransplantation.